Answers are grounded in this paper and cite their sources.
A clinically acceptable modified erythrocyte concentrate with long shelf-life can now be readily provided even after complete removal of all available plasma for fractionation. The concentrates have been evaluated in an uneventful clinical trial.
No takes yet. Share an insight, caveat, or question.
Lovric et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: